ELI LILLY & Co (LLY) revenue & profit

ELI LILLY & Co (LLY): revenue $65.2B, net income $20.6B in 2025; latest quarter +47.7% year over year. From SEC filings.

$65.2BRevenue 2025

TickerLLY (NYSE)

IndustryHealthcare · Pharmaceutical Preparations

Revenue 2025$65.2B

Net income 2025$20.6B

Net margin31.7%

Annual revenue growth+44.7%

Latest quarter (2026 Q2) · Revenue$23B

vs. same quarter last year+47.7%

Latest quarter · Net income$7.1B

Annual revenue & net income

Year	Revenue	Net income
2022	$28.5B	$6.2B
2023	$34.1B	$5.2B
2024	$45B	$10.6B
2025	$65.2B	$20.6B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · Eli Lilly and Company, converted to PNG by Huwmanbeing · Public domain · Wikimedia Commons

📷 Momoneymoproblemz · CC BY-SA 4.0 · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.